Evidence map›Paper›PMID 7644542›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1995

Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors.

R K Lee, R J Wurtman, A J Cox, R M Nitsch

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 180 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

R K LeeDepartment of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge 02139, USA.
R J Wurtman
A J Cox
R M Nitsch
Massachusetts Institute of Technology · US

Funding

PSYCHOPHARMACOLOGICAL EFFECTS OF EXOGENOUS CHOLINER01MH028783 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WURTMAN, RICHARD J · 1985 to 2008
$3.5M
PSYCHOPHARMACOLOGICAL EFFECTS OF EXOGENOUS CHOLINER37MH028783 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WURTMAN, RICHARD J · 1989 to 1998
–
NIMH NIH HHS MH28783
6 · The paper itself

Abstract

Stimulation of muscarinic m1 or m3 receptors can, by generating diacylglycerol and activating protein kinase C, accelerate the breakdown of the amyloid precursor protein (APP) to form soluble, nonamyloidogenic derivatives (APPs), as previously shown. This relationship has been demonstrated in human glioma and neuroblastoma cells, as well as in transfected human embryonic kidney 293 cells and PC-12 cells. We now provide evidence that stimulation of metabotropic glutamate receptors (mGluRs), which also are coupled to phosphatidylinositol 4,5-bisphosphate hydrolysis, similarly accelerates processing of APP into nonamyloidogenic APPs. This process is demonstrated both in hippocampal neurons derived from fetal rats and in human embryonic kidney 293 cells transfected with cDNA expression constructs encoding the mGluR 1 alpha subtype. In hippocampal neurons, both an mGluR antagonist, L-(+)-2-amino-3-phosphonopropionic acid, and an inhibitor of protein kinase C, GF 109203X, blocked the APPs release evoked by glutamate receptor stimulation. Ionotropic glutamate agonists, N-methyl-D-aspartate or S(-)-5-fluorowillardiine, failed to affect APPs release. These data show that selective mGluR agonists that initiate signal-transduction events can regulate APP processing in bona fide primary neurons and transfected cells. As glutamatergic neurons in the cortex and hippocampus are damaged in Alzheimer disease, amyloid production in these regions may be enhanced by deficits in glutamatergic neurotransmission.

Indexed as

Protein Processing, Post-TranslationalAlanineAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAnimalsCell LineChelating AgentsCycloleucineEmbryo, MammalianFetusGliomaGlutamic AcidHippocampusHumansIndolesKidney1-amino-1,3-dicarboxycyclopentane2-amino-3-phosphonopropionic acid5-fluorowillardiineAlanineAmyloid beta-PeptidesAmyloid beta-Protein Precursorbisindolylmaleimide IChelating AgentsCycloleucineGlutamic AcidIndolesMaleimidesNeurotoxinsN-MethylaspartatePhosphatidylinositol 4,5-DiphosphatePhosphatidylinositol PhosphatesProtein Kinase CPyrimidinesQuinacrineQuisqualic AcidReceptors, Metabotropic GlutamateRecombinant ProteinsTetradecanoylphorbol AcetateNon-programmatic

Identifiers

PMID7644542
PMCPMC41291
OpenAlexW2033033457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.